J. Stonebraker

发表

Impact factor as a metric to assess journals where OM research is published

R. Handfield, C. Kirkwood, J. Stonebraker, 2012 .

Modelling haemophilia epidemiology and treatment modalities to estimate the unconstrained factor VIII demand

J. Stonebraker, P. Larson, R. Amand, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

Evaluation of the sexual health in people living with hemophilia

A. Iorio, J. Stonebraker, F. Germini, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Risk analysis, practice, and considerations in capital budgeting: Evidence from the field for the bio-based industry

J. Stonebraker, Sudipta Dasmohapatra, H. Jameel, 2020, BioResources.

Non‐severe haemophilia: Is it benign? – Insights from the PROBE study

A. Iorio, J. Stonebraker, F. Germini, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire

Jeffrey S. Stonebraker, A. Iorio, J. Stonebraker, 2017, BMJ Open.

Bayer Makes Decisions to Develop Drugs

J. Stonebraker, 2005 .

A study of variations in the reported haemophilia A prevalence around the world

Jeffrey S. Stonebraker, J. Stonebraker, J. Soucie, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Exploring regional variations in the cross‐cultural, international implementation of the Patient Reported Outcomes Burdens and Experience (PROBE) study

Jeffrey S. Stonebraker, A. Iorio, J. Stonebraker, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males

Jeffrey S. Stonebraker, A. Iorio, J. Stonebraker, 2019, Annals of Internal Medicine.

A study of variations in the reported haemophilia B prevalence around the world

Jeffrey S. Stonebraker, J. Stonebraker, J. Soucie, 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

Measuring the quality of haemophilia care across different settings: a set of performance indicators derived from demographics data

A. Iorio, J. Stonebraker, J. Soucie, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

OR Practice - Modeling Potential Demand for Supply-Constrained Drugs: A New Hemophilia Drug at Bayer Biological Products

Donald L. Keefer, Jeffrey S. Stonebraker, D. Keefer, 2009, Oper. Res..

The World Federation of Hemophilia Annual Global Survey 1999‐2018

Jeffrey S. Stonebraker, A. Iorio, J. Stonebraker, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

A study of reported factor IX use around the world

J. Stonebraker, A. Srivastava, P. Bolton-Maggs, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

A study of reported factor VIII use around the world

J. Stonebraker, A. Srivastava, A. Farrugia, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia

J. Stonebraker, M. Nichol, C. Chai-Adisaksopha, 2018, Pilot and Feasibility Studies.

Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over time

Jeffrey S. Stonebraker, A. Iorio, J. Stonebraker, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Modelling future usage and cost of factor and emicizumab to treat haemophilia A for the US Western States Region IX haemophilia treatment centres

J. Stonebraker, J. Ducore, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

A country‐by‐country comparison of FVIII concentrate consumption and economic capacity for the global haemophilia community

J. Stonebraker, R. Amand, A. J. Nagle, 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

Product-Generation Transition Decision Making for Bayer's Hemophilia Drugs: Global Capacity Expansion Under Uncertainty with Supply-Demand Imbalances

Jeffrey S. Stonebraker, J. Stonebraker, 2013, Oper. Res..

Modeling Primary Immunodeficiency Disease Epidemiology and Its Treatment to Estimate Latent Therapeutic Demand for Immunoglobulin

Jeffrey S. Stonebraker, J. Orange, J. Stonebraker, 2014, Journal of Clinical Immunology.

Test‐retest properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire and its constituent domains

Jeffrey S. Stonebraker, A. Iorio, J. Stonebraker, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Latent therapeutic demand model for the immunoglobulin replacement therapy of primary immune deficiency disorders in the USA

Jeffrey S. Stonebraker, J. Orange, J. Stonebraker, 2018, Vox sanguinis.

The Application of Decision Analysis Methods to Source Selection in the United States Air Force

Vernon E. Francis, Vernon E Francis, Jeffrey S Stonebraker, 1991 .

Von Willebrand disease: Gaining a global perspective.

J. Stonebraker, M. Makris, P. James, 2023, Haemophilia : the official journal of the World Federation of Hemophilia.